Cervical cancer screening practices inefficient, costly
Current cervical cancer screening practices are inefficient and not cost-effective, according to a new study led by a Harvard T.H. Chan School of Public Health researcher. Some women are tested too often, while others are underscreened, and follow-up…
In praise of postdocs
October 7, 2014 -- About 50 postdocs and their mentors celebrated Harvard School of Public Health’s “Postdoc Appreciation Day” on September 19, 2014, which was held in conjunction with National Postdoc Appreciation Week as a formal “thank you”…
New findings that young men also benefit from HPV vaccine may warrant reconsideration of vaccination guidelines, HSPH researcher says
New findings reported in The New England Journal of Medicine suggest that vaccinating young men against human papillomavirus (HPV) that cause the majority of cervical and anal cancers, and a smaller proportion of other cancers, resulted in reduced…
Infectious disease: HPV vaccine appears to be cost-effective way to prevent anal cancer in young males
Jane Kim, assistant professor of health decision science at HSPH, is the author of a study in The Lancet Infectious Diseases on the cost-effectiveness of the human papillomavirus (HPV) vaccine in young men and teen boys. Kim was…
Vaccinating boys against Human Papillomavirus (HPV) not cost-effective
Cervical Cancer Prevention Efforts Should Prioritize Vaccinating Pre-Adolescent Girls and Continued Cervical Cancer Screening For immediate release: Thursday, October 8, 2009 Boston, MA -- Persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus, is…